02 September, 2026 | Wednesday | News

 Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreement with the U.S. government that reflects our commitment...

04 September, 2026 | Friday | News

Dedicated absorbance reader helps academic, biotech, pharmaceutical and quality control labs generate reliable data for common biological assays with straightforward operation Thermo Fisher Scientific announce...

03 September, 2026 | Thursday | News

Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400 institutions across 33 countries ordering DNA construc...

14 September, 2026 | Monday | News

Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd. ("ForYou Medical"), a China-based contract developmen...

10 September, 2026 | Thursday | News

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days,...

14 September, 2026 | Monday | News

-MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) announced  that the first participant has been dosed in the global Phase I/II trial of JR-...

04 September, 2026 | Friday | News

Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the expansion...